MULTI-OUTPUT PACKET SERVER WITH INDEPENDENT STREAMS

Details for Australian Patent Application No. 2002245606 (hide)

Owner DIGITAL FOUNTAIN, INC.

Inventors SIMU, Serban; PERRIG, Adrian; ATTIAS, Roberto; WALFISH, Michael; HERNEK, Diane; BYERS, John; LUBY, Michael; VAINISH, Ronen; RASMUSSEN, Lars; KUSHI, David

Pub. Number AU-A-2002245606

PCT Pub. Number WO2002/073427

Priority 60/274,445 09.03.01 US; 09/882,508 15.06.01 US

Filing date 5 March 2002

Wipo publication date 24 September 2002

International Classifications

G06F 013/00 Interconnection of, or transfer of information or other signals between, memories, input/output devices or central processing units

G06F 015/16 Digital computers in general - Combinations of two or more digital computers each having at least an arithmetic unit, a programme unit and a register, e.g. for a simultaneous processing of several programmes

H04L 012/00 Data switching networks

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002245606

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245607-METHOD AND APPARATUS FOR REDUCING SPECULAR REFLECTION FROM A SCANNABLE SURFACE

2002245605-4-(2-Butylamino)-2,7-dimethyl-8-(2-met hyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-a]-1,3,5triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands